Back to School: How biopharma can reboot drug development. Access exclusive analysis here
The Alcon Inc. ophthalmic unit of Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland) said Health Canada approved Jetrea ocriplasmin to
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury